Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mesoblast Limited (AU:MSB)
ASX:MSB
Mesoblast Limited (MSB) Share Price & Analysis
76 Followers
MSB Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.26 - AU$1.33
Previous CloseAU$1.13
Volume585.77K
Average Volume (3M)8.53M
Market Cap
AU$1.28B
Enterprise ValueAU$1.35B
Total Cash (Recent Filing)$71.51M
Total Debt (Recent Filing)$116.50M
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Aug 28, 2024EPS Estimate
-AU$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding1,141,784,114
10 Day Avg. Volume4,547,140
30 Day Avg. Volume8,533,277
Standard Deviation0.28
R-Squared0.23
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-2.48
Price to Sales (P/S)554.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue239.13
Enterprise Value/Gross Profit180.03
Enterprise Value/Ebitda-29.43
Forecast
1Y Price Target
AU$1.10Price Target Upside-0.55% Downside
Rating ConsensusHold
Number of Analyst Covering1
Mesoblast Limited News
PremiumCompany Announcements
Mesoblast Director’s Holdings Surge Post-AGM
PremiumCompany Announcements
Mesoblast Issues 3.5M Unquoted Employee Options
PremiumCompany Announcements
Mesoblast Reports Unmet Conditions Lead to Cessation of Options
PremiumCompany Announcements
Mesoblast Seeks FDA Approval for Pediatric SR-aGVHD Therapy
PremiumCompany Announcements
Mesoblast Prepares FDA Submission for Ryoncil
PremiumCompany Announcements
Mesoblast Targets FDA Approval with RyoncilOptions Prices
Currently, No data available
---
Ownership Overview
7.37% Insiders
2.30% Mutual Funds
1.40% Other Institutional Investors
88.93% Public Companies and
Individual Investors
MSB FAQ
What was Mesoblast Limited’s price range in the past 12 months?
Mesoblast Limited lowest share price was AU$0.26 and its highest was AU$1.33 in the past 12 months.
What is Mesoblast Limited’s market cap?
Currently, no data Available
When is Mesoblast Limited’s upcoming earnings report date?
Mesoblast Limited’s upcoming earnings report date is Aug 28, 2024 which is in 40 days.
How were Mesoblast Limited’s earnings last quarter?
Currently, no data Available
Is Mesoblast Limited overvalued?
According to Wall Street analysts Mesoblast Limited’s price is currently Overvalued.
Does Mesoblast Limited pay dividends?
Mesoblast Limited does not currently pay dividends.
What is Mesoblast Limited’s EPS estimate?
Mesoblast Limited’s EPS estimate is -AU$0.04.
How many shares outstanding does Mesoblast Limited have?
Mesoblast Limited has 1,141,784,000 shares outstanding.
What happened to Mesoblast Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mesoblast Limited?
Currently, no hedge funds are holding shares in AU:MSB
---
Mesoblast Limited Stock Smart Score
Company Description
Mesoblast Limited
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
---
MSB Company Deck
---
MSB Earnings Call
Q2 2024
0:00 / 0:00
---
MSB Stock 12 Month Forecast
Average Price Target
AU$1.10
▼(-0.55% Downside)
Technical Analysis
Mesoblast Limited
―
Sarepta Therapeutics
―
Crispr Therapeutics AG
―
Vericel
―
Alnylam Pharma
―
---